Wall Street Analysts Think Corcept (CORT) Could Surge 41.31%: Read This Before Placing a Bet

Shares of Corcept Therapeutics (CORT) have gained 31.1% over the past four weeks to close the last trading session at $46.28, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$65.40 indicates a potential upside of 41.3%. The average comprises five short-term price targets ranging from a low of $45 to a high of$78, with a standard deviation of $12.46. While the lowest estimate in ...